Answers are grounded in this paper and cite their sources.
Marine- and plant-derived omega-3 fatty acids, including eicosapentaenoic acid, docosahexaenoic acid, and alpha-linolenic acid, are bioactive nutrients that may influence colorectal cancer (CRC) biology through regulation of inflammatory signaling, lipid metabolism, and cellular stress responses. These fatty acids can modulate membrane composition, lipid-mediated signaling pathways, oxidative balance, and tumor microenvironment-associated processes. Preclinical studies suggest that omega-3 fatty acids may regulate inflammatory pathways, immune responses, angiogenesis, and epithelial–mesenchymal transition; however, their direct effects on CRC treatment response and drug resistance require further clarification. Apigenin, a dietary flavonoid found in fruits, vegetables, and medicinal plants, has been investigated for anticancer activities in experimental CRC models. It has been reported to affect key pathways involved in CRC progression, including glycolytic regulation, oxidative stress, apoptosis, autophagy, and cell-cycle control. Although apigenin has shown potential interactions with anticancer pathways and therapeutic responses in preclinical studies, clinical evidence remains limited. This review summarizes current mechanistic and translational evidence regarding omega-3 fatty acids and apigenin in CRC, focusing on inflammation, immune regulation, metabolic adaptation, tumor microenvironment remodeling, and cellular stress responses. We also discuss important translational limitations, including bioavailability, clinically achievable concentrations, heterogeneity among experimental models, and the absence of clinical studies evaluating combined omega-3 fatty acid and apigenin interventions. Overall, omega-3 fatty acids and apigenin represent biologically relevant compounds that have been investigated for their effects on multiple pathways associated with CRC development and progression; however, their therapeutic applicability and potential interactions require validation through rigorous experimental and clinical investigations.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: